170 related articles for article (PubMed ID: 36874429)
1. Thyrotoxicosis in patients with a history of Graves' disease after SARS-CoV-2 vaccination (adenovirus vector vaccine): Two case reports.
Yan BC; Luo RR
World J Clin Cases; 2023 Feb; 11(5):1122-1128. PubMed ID: 36874429
[TBL] [Abstract][Full Text] [Related]
2. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.
Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB
Front Public Health; 2021; 9():778964. PubMed ID: 34888290
[No Abstract] [Full Text] [Related]
3. Four cases of Graves' disease following viral vector severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) vaccine.
Chaudhary S; Dogra V; Walia R
Endocr J; 2022 Dec; 69(12):1431-1435. PubMed ID: 35979558
[TBL] [Abstract][Full Text] [Related]
4. Graves' disease after exposure to the SARS-CoV-2 vaccine: a case report and review of the literature.
Takedani K; Notsu M; Ishiai N; Asami Y; Uchida K; Kanasaki K
BMC Endocr Disord; 2023 Jun; 23(1):132. PubMed ID: 37316819
[TBL] [Abstract][Full Text] [Related]
5. HLA typing of patients who developed subacute thyroiditis and Graves' disease after SARS-CoV-2 vaccination: a case report.
Yasuda S; Suzuki S; Yanagisawa S; Morita H; Haisa A; Satomura A; Nakajima R; Oikawa Y; Inoue I; Shimada A
BMC Endocr Disord; 2023 Mar; 23(1):54. PubMed ID: 36879263
[TBL] [Abstract][Full Text] [Related]
6. Graves' Disease Following SARS-CoV-2 Vaccination: A Systematic Review.
Patrizio A; Ferrari SM; Elia G; Ragusa F; Paparo SR; Mazzi V; Antonelli A; Fallahi P
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146523
[TBL] [Abstract][Full Text] [Related]
7. Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion.
Pla Peris B; Merchante Alfaro AÁ; Maravall Royo FJ; Abellán Galiana P; Pérez Naranjo S; González Boillos M
J Endocrinol Invest; 2022 May; 45(5):1071-1077. PubMed ID: 35015288
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 mRNA Vaccination and Graves' Disease: A Report of 12 Cases and Review of the Literature.
Chee YJ; Liew H; Hoi WH; Lee Y; Lim B; Chin HX; Lai RTR; Koh Y; Tham M; Seow CJ; Quek ZH; Chen AW; Quek TPL; Tan AWK; Dalan R
J Clin Endocrinol Metab; 2022 May; 107(6):e2324-e2330. PubMed ID: 35235663
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves' Disease.
Huang L; Jiang Z; Zhou J; Chen Y; Huang H
Front Endocrinol (Lausanne); 2022; 13():835880. PubMed ID: 35651979
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management.
Caron P
Endocrine; 2022 Dec; 78(3):406-417. PubMed ID: 35763241
[TBL] [Abstract][Full Text] [Related]
11. Relapsed and newly diagnosed Graves' disease due to immunization against COVID-19: A case series and review of the literature.
Bostan H; Ucan B; Kizilgul M; Calapkulu M; Hepsen S; Gul U; Ozturk Unsal I; Cakal E
J Autoimmun; 2022 Apr; 128():102809. PubMed ID: 35220164
[TBL] [Abstract][Full Text] [Related]
12. New Onset or Deterioration of Thyroid Eye Disease After mRNA SARS-CoV-2 Vaccines: Report of 2 Cases and Literature Review.
Mohamed A; Tzoulis P; Kossler AL; Dosiou C
J Clin Endocrinol Metab; 2023 Mar; 108(4):979-985. PubMed ID: 36251747
[TBL] [Abstract][Full Text] [Related]
13. New-onset Graves' disease following SARS-CoV-2 vaccination: a case report.
Manta R; Martin C; Muls V; Poppe KG
Eur Thyroid J; 2022 Aug; 11(4):. PubMed ID: 35900872
[TBL] [Abstract][Full Text] [Related]
14. Graves' orbitopathy post-SARS-CoV-2 vaccines: report on six patients.
Abeillon-du Payrat J; Grunenwald S; Gall E; Ladsous M; Raingeard I; Caron P
J Endocrinol Invest; 2023 Mar; 46(3):617-627. PubMed ID: 36378488
[TBL] [Abstract][Full Text] [Related]
15. Thyroid Inflammation and Immunity During the COVID-19 Pandemic: A Comprehensive Review and Case Study.
Lampropoulou E; Benz C; Kahaly GJ; Führer D
Horm Metab Res; 2024 Feb; 56(2):111-117. PubMed ID: 38049146
[TBL] [Abstract][Full Text] [Related]
16. Thyroid Inconveniences With Vaccination Against SARS-CoV-2: The Size of the Matter. A Systematic Review.
Caironi V; Pitoia F; Trimboli P
Front Endocrinol (Lausanne); 2022; 13():900964. PubMed ID: 35813627
[TBL] [Abstract][Full Text] [Related]
17. Thyroid Eye Disease as Initial Manifestation of Graves' Disease Following Viral Vector SARS-CoV-2 Vaccine: Report of a Case and Review of the Literature.
Armeni AK; Markantes GΚ; Stathopoulou A; Saltiki K; Zampakis P; Assimakopoulos SF; Michalaki MA
Vaccines (Basel); 2023 Oct; 11(10):. PubMed ID: 37896977
[TBL] [Abstract][Full Text] [Related]
18. Two Cases of Severe Autoimmune Thyrotoxicosis Following SARS-CoV-2 Infection.
Edwards K; Hussain I
J Investig Med High Impact Case Rep; 2021; 9():23247096211056497. PubMed ID: 34844465
[TBL] [Abstract][Full Text] [Related]
19. Increased incidence of Graves' disease during the SARS-CoV2 pandemic.
Barajas Galindo DE; Ramos Bachiller B; González Roza L; García Ruiz de Morales JM; Sánchez Lasheras F; González Arnáiz E; Ariadel Cobo D; Ballesteros Pomar MD; Rodríguez IC
Clin Endocrinol (Oxf); 2023 May; 98(5):730-737. PubMed ID: 36510647
[TBL] [Abstract][Full Text] [Related]
20. Graves' Thyrotoxicosis Following SARS-CoV-2 Infection.
Harris A; Al Mushref M
AACE Clin Case Rep; 2021; 7(1):14-16. PubMed ID: 33521256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
